Cargando…
Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis
Jinlong capsule (JLC), a type of herbal medicine, is considered to be a promising adjuvant therapy for hepatocellular carcinoma (HC). Although an analysis of the published literature has been performed, the exact effects and safety of JLC are yet to be systematically investigated. Therefore, a wide-...
Autores principales: | Xu, He, Wei, Wenjie, Y., Mu, Dong, Chengwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970085/ https://www.ncbi.nlm.nih.gov/pubmed/31872855 http://dx.doi.org/10.1042/BSR20194019 |
Ejemplares similares
-
Chinese patent medicine (Jinlong Capsule) for gastric cancer: Protocol for a systematic review and meta-analysis
por: Li, Jianwei, et al.
Publicado: (2020) -
Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population
por: Jia, Shuzhao, et al.
Publicado: (2020) -
Jinlong capsule inhibits migration and invasion in human glioblastoma cells via the modulation of mTOR/S6 signaling pathway
por: Shi, Jingren, et al.
Publicado: (2019) -
The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Liu, Jingjing, et al.
Publicado: (2019) -
Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Chuihua, et al.
Publicado: (2021)